$12.13
0.25% today
Nasdaq, Apr 03, 06:36 pm CET
ISIN
US6373722023
Symbol
NRC

National Research Corporation Stock price

$12.16
-1.99 14.06% 1M
-8.92 42.32% 6M
-5.48 31.07% YTD
-24.42 66.76% 1Y
-27.04 68.98% 3Y
-31.68 72.26% 5Y
+0.42 3.61% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
-0.66 5.15%
ISIN
US6373722023
Symbol
NRC
Sector

Key metrics

Market capitalization $279.02m
Enterprise Value $338.64m
P/E (TTM) P/E ratio 11.65
EV/FCF (TTM) EV/FCF 17.66
EV/Sales (TTM) EV/Sales 2.37
P/S ratio (TTM) P/S ratio 1.95
P/B ratio (TTM) P/B ratio 8.97
Dividend yield 3.95%
Last dividend (FY24) $0.48
Revenue growth (TTM) Revenue growth -3.72%
Revenue (TTM) Revenue $143.06m
EBIT (operating result TTM) EBIT $35.45m
Free Cash Flow (TTM) Free Cash Flow $19.18m
Cash position $4.23m
EPS (TTM) EPS $1.04
Short interest 2.53%
Show more

Is National Research Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

National Research Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a National Research Corporation forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a National Research Corporation forecast:

Hold
100%

Financial data from National Research Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
143 143
4% 4%
100%
- Direct Costs 63 63
2% 2%
44%
80 80
8% 8%
56%
- Selling and Administrative Expenses 39 39
5% 5%
27%
- Research and Development Expense - -
-
-
41 41
10% 10%
29%
- Depreciation and Amortization 6.02 6.02
2% 2%
4%
EBIT (Operating Income) EBIT 35 35
12% 12%
25%
Net Profit 25 25
20% 20%
17%

In millions USD.

Don't miss a Thing! We will send you all news about National Research Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

National Research Corporation Stock News

Neutral
Business Wire
10 days ago
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025. For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize ...
Neutral
Business Wire
30 days ago
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare improvement, is pleased to announce the appointment of Trent Green as its incoming Chief Executive Officer, effective June 1, 2025. Green will succeed Mike Hays, the company's current CEO, who will transition to the role of Chairman, ensuring a smooth...
Neutral
Business Wire
about one month ago
LOUISVILLE, Ky.--(BUSINESS WIRE)-- #EmployeeExperience--UofL Health selects NRC Health to elevate patient and employee experience across its health system.
More National Research Corporation News

Company Profile

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.

Head office United States
CEO Michael Hays
Employees 368
Founded 1981
Website www.nrchealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today